American Public Opinion on E-cigarette Regulation: Gallup Survey

Aug.28.2022
American Public Opinion on E-cigarette Regulation: Gallup Survey
A Gallup survey found that 60% of Americans want stricter regulation of e-cigarettes following the Juul ban.

After the Juul ban, Gallup conducted a survey to determine the opinions of Americans on the FDA's proposed ban on menthol cigarettes.


Latest Investigation on Regulations concerning E-cigarettes


Gallup conducted a recent survey on American attitudes towards e-cigarette regulations and tobacco. The study came to the following conclusions:


Six out of every ten Americans want stricter regulation of e-cigarettes, according to a Gallup poll conducted between July 5 and July 28. Interestingly, this sentiment is shared across both political parties, with over half of Republicans, Independents, and Democrats hoping for tougher laws regarding e-cigarettes. The poll was conducted after a vote by the US Food and Drug Administration in support of a ban on Juul products.


The Views of Americans on Regulating E-cigarettes


Gallup's annual consumer survey gathered opinions from Americans on regulating electronic cigarettes. These views varied among men, women, and different age groups.


A survey has found that 61% of American adults believe there should be stricter regulations on electronic cigarettes, while 30% think the current rules are sufficient. Meanwhile, 7% feel the laws should be relaxed. Broken down by political party affiliation, 69% of Democrats are in favor of more stringent e-cigarette laws, while 28% believe the laws should remain unchanged. However, only 2% want the rules to be less severe. Among Independents, 60% prefer stricter laws, while 30% approve of current regulations. Nevertheless, 9% wish for less strict rules. Republicans were also part of the poll, with 53% voting in favor of tighter e-cigarette laws, 10% hoping for less strict regulation, and 32% wanting laws to stay as they are. According to a Gallup report, the number of Americans smoking has declined in the past decade, which may be attributed to the introduction of e-cigarette regulation. In the last four years, statistics show that 8% of Americans have used e-cigarettes.


A recent Gallup survey revealed that only 11% of Americans smoke, as of the week prior to the poll. This is significantly lower than the initial 20% record from the past decade.


The public supports reducing the amount of nicotine in cigarettes, but does not support a ban on menthol.


A Gallup public opinion poll covered three proposed electronic cigarette regulations currently under consideration in Washington, D.C. These regulations aim to reduce smoking among Americans. While the responses varied, there was only party agreement reached on one of the regulations.


The first regulation requires tobacco companies to lower nicotine levels in e-cigarettes. Compliance with this law is expected to reduce nicotine addiction. Approximately three-quarters of American adults support this measure, according to opinion polls. Surprisingly, supporters include a majority of Republicans. Most independents and Democrats are also not excluded.


A recent opinion poll has revealed the thoughts of Americans regarding a proposal to double the federal cigarette tax in Congress. The implementation of this policy would mean that the federal cigarette tax would increase from $1.01 to $2.02 per pack. 55% of adults support this policy, with the majority being Democrats and Independents.


Unlike the other two policies, the third policy does not have widespread support among Americans. The US Food and Drug Administration (FDA) has proposed a ban on menthol-flavored cigarettes, stating that the use of menthol often increases the appeal of cigarettes to young people. However, only 42% of Americans support this policy.


Statement


This article is compiled from third-party information and is intended for sharing and learning within the industry.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truthfulness or accuracy of its content. The translation of this article is intended solely for industry research and communication.


Due to limitations in our ability to translate, the translated article may not fully reflect the original text. Please refer to the original article for accuracy.


In regards to any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions, 2FIRSTS is fully aligned with the Chinese government.


The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Q4 Revenue Rebounds 33% but Full-Year Sales Still Fall 25% as FY2027 Focus Shifts to Malaysia Manufacturing, ODM, Nicotine Pouches and Age Verification
Ispire Technology reported FY2026 revenue of about $96 million, down 24.7% year over year, as U.S. cannabis-vapor hardware and European e-cigarette sales declined by $17.4 million and $12.7 million, respectively. Fourth-quarter revenue rose 32.5% to $26.7 million, while quarterly gross margin fell to 6.3%. For FY2027, the company is prioritizing Malaysia manufacturing and vapor ODM while continuing to develop nicotine pouches, IKE Tech age-verification technology and G-Mesh licensing. Ispire has not separately disclosed the revenue or profit contribution of those newer businesses.
Regulations
Sep.17 by 2Firsts Perspectives
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
U.S. Ninth Circuit Upholds FDA Denial of MH Global’s Flavored Vape PMTA Applications
The U.S. Court of Appeals for the Ninth Circuit upheld the FDA’s denial of MH Global LLC’s applications to market flavored electronic nicotine delivery systems (ENDS). The court ruled that FDA’s comparative-efficacy framework, which requires applicants to show that flavored products provide greater cessation or switching benefits than tobacco-flavored alternatives, is consistent with the Tobacco Control Act’s “appropriate for the protection of the public health” standard. The court also found that FDA was not required to establish the framework through notice-and-comment rulemaking.
Aug.26
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australia’s Coalition has unveiled a national illicit-tobacco policy that would cut tobacco excise by 80% and create legal, regulated and taxed adult markets for vaping products and nicotine pouches if it wins government. The plan proposes an excise of A$0.50 per millilitre of e-liquid and A$0.025 per milligram of nicotine in pouches, alongside A$200 million in additional enforcement and a A$60 million three-year public-awareness campaign. The Coalition says the package would narrow the price advantage of illicit products and undermine organised crime, while Labor and public-health groups warn that dramatically cheaper cigarettes could reverse long-term declines in smoking.
Sep.03
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03